Adamas Pharmaceuticals

$8.22

+$0.06 (+0.74%) Today
$0.00 (0.00%) As of 10:55 PM UTC after-hours
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch ADMS and buy or sell other stocks, options, and ETFs commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
Employees
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2000
Founded2000
Employees
Employees

ADMS Key Statistics

Market cap
375.58M
Market cap375.58M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
964.73K
Average volume964.73K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$9.15
52 Week high$9.15
52 Week low
$4.02
52 Week low$4.02

Analyst ratings

ADMS Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
per share
Estimated per share
Actual
Expected Aug 8, After Hours
ActualExpected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.